Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.
Of the 6 companies Oncology Institute, Inc. moves with most closely, none share its SEC classification.
Measured against 491 trading days of our own closes. Co-movement, not cause.
SIC 8011, Services-Offices & Clinics of Doctors of Medicine, from each company's own filings. Largest first.
No case yet. It builds on the next filing, report or 13F period.
tall tick = annual report · 1 on record
Starling Oncology, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Offices & Clinics of Doctors of Medicine
High 7.09 at 9:45 am ET, low 6.64 at 8:15 am ET.
119 managers report a position worth $233.3M between them, and 20 of them hold 80% of it.
TOI (Starling Oncology, Inc.) has 2 disclosed suppliers and 6 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.